Veröffentlicht am in "Business, Business", Sprache — English. 4 Seiten.
Global plasma protease C1-inhibitor treatment market is expected to grow at the highest CAGR in the upcoming years. C1-inhibitor is also known as C1-INH and C1 esterase inhibitor. C1-INH’s deficiency is the genetic defect underlying hereditary angioedema (HAE). Mehr anzeigen
